Neutrophil-produced CCL4L2 was negatively related to inhaled corticosteroid (ICS) responsiveness in asthmatics and has been suggested as a potential therapeutic target for ICS-refractory asthma [35]. The gene discussed is CCL4L2; the disease is asthma.